Replay available

Genomma Lab Intl Sab Ord (GNMLF) Q2 2024 Earnings Call

Genomma Lab Intl Sab Ord (OTC: GNMLF) Q2 2024 earnings conference call, held 2024-07-25. Replay captured from the company's public earnings webcast.

Thu, July 25, 2024 at 1:00 PMendedReplay
Genomma Lab Intl Sab Ord (GNMLF) Q2 2024 Earnings Call

Hosted by

Featured presenters

Christian Ibanez

Head of Investor Relations

Alvaro Garcia

Analyst, BTG

Bruno Ramirez

Analyst, JP Morgan

Antonio Hernandez

Analyst, Actinver

Fernando Herrera

Analyst, Compass Group

Marcos Barbieri

Chief Executive Officer

Antonio Zamora

Chief Financial Officer

Sara Maldonado

Analyst, Santander

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genomma Lab Internacional Sab De Cv Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.069 -- 00:00:05.451 Ladies and gentlemen, thank you for joining Genoma Lab's second quarter 2024 00:00:05.451 -- 00:00:08.012 earnings conference call. 00:00:08.012 -- 00:00:11.653 All participants will be in listen-only mode. 00:00:11.653 -- 00:00:16.655 After today's presentation, there will be an opportunity to ask questions. 00:00:16.655 -- 00:00:21.677 As a reminder, this meeting is being recorded and will be available for replay 00:00:21.677 -- 00:00:27.441 from the Investor Relations section of Genoma's website following the call. 00:00:27.441 -- 00:00:32.342 I'll now turn the call over to Christian Ibanez, Genoma's Head of Investor Relations. 00:00:32.342 -- 00:00:35.343 Please, go ahead. 00:00:35.944 -- 00:00:40.985 Thank you and welcome, everyone. On today's call are Marcos Barbieri, Chief 00:00:40.985 -- 00:00:45.526 Executive Officer, and Antonio Zamora, Chief Financial Officer. 00:00:45.526 -- 00:00:50.388 Before we get started, I'd like to remind you that the remarks today will include forward-looking 00:00:50.388 -- 00:00:55.713 statements such as the company's financial guidance and expectations, including long-term 00:00:55.713 -- 00:01:00.959 objectives and forecasts, as well as expectations regarding Genoma's business, 00:01:00.959 -- 00:01:04.864 assets, products, strategies, demand, and markets. 00:01:04.864 -- 00:01:09.289 These statements are subject to risks and uncertainties that could cause actual results 00:01:09.289 -- 00:01:14.133 to differ materially. They are also based on assumptions as of today, and the company 00:01:14.133 -- 00:01:19.277 undertakes no obligation to update them as a result of new information or future 00:01:19.277 -- 00:01:23.539 events. Let me now turn the call over to Marco. 00:01:25.702 -- 00:01:31...